These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10960678)

  • 1. Immunologic mechanisms in granulomatous lung disease.
    Newman LS
    Immunopharmacology; 2000 Jul; 48(3):329-31. PubMed ID: 10960678
    [No Abstract]   [Full Text] [Related]  

  • 2. Bronchoalveolar lavage macrophage-lymphocyte clusters in granulomatous disease are linked to lymphocytosis.
    Bauer RA; Sawyer RT; Daniloff E; Balkissoon R; Rose CS; Newman LS
    Sarcoidosis Vasc Diffuse Lung Dis; 2000 Jun; 17(2):174-80. PubMed ID: 10957766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-beta 1 variants in chronic beryllium disease and sarcoidosis.
    Jonth AC; Silveira L; Fingerlin TE; Sato H; Luby JC; Welsh KI; Rose CS; Newman LS; du Bois RM; Maier LA;
    J Immunol; 2007 Sep; 179(6):4255-62. PubMed ID: 17785866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beryllium-induced disturbances of the murine immune system reflect some phenomena observed in sarcoidosis.
    Pfeifer S; Bartlett R; Strausz J; Haller S; Müller-Quernheim J
    Int Arch Allergy Immunol; 1994 Aug; 104(4):332-9. PubMed ID: 8038611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchoalveolar lavage in a patient with chronic berylliosis: evidence for hypersensitivity pneumonitis.
    Epstein PE; Dauber JH; Rossman MD; Daniele RP
    Ann Intern Med; 1982 Aug; 97(2):213-6. PubMed ID: 7103279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic response of sarcoidosis.
    Zissel G; Prasse A; Müller-Quernheim J
    Semin Respir Crit Care Med; 2010 Aug; 31(4):390-403. PubMed ID: 20665389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is chronic beryllium disease sarcoidosis of known etiology?
    Rossman MD; Kreider ME
    Sarcoidosis Vasc Diffuse Lung Dis; 2003 Jun; 20(2):104-9. PubMed ID: 12870719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-presentation of beryllium by BAL CD4+ T cells: T cell-T cell interactions and their potential role in chronic beryllium disease.
    Fontenot AP; Edwards DM; Chou YK; Mack DG; LaTocha D; Vandenbark AA; Burrows GG
    Eur J Immunol; 2006 Apr; 36(4):930-9. PubMed ID: 16552706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [T lymphocytes in sarcoidosis].
    Tazi A; Hance AJ
    Presse Med; 1999 Oct; 28(31):1723-8. PubMed ID: 10554616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Processing and presentation of tetanus toxin by antigen-presenting cells from patients with chronic granulomatous disease (CGD) to human specific T cell clones are not impaired.
    Barbey C; Tiercy JM; Fairweather N; Niemann H; Seger R; Corradin G
    Clin Exp Immunol; 1994 Feb; 95(2):227-31. PubMed ID: 8306496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic beryllium disease: T cell recognition of a metal presented by HLA-DP.
    Fontenot AP; Newman LS; Kotzin BL
    Clin Immunol; 2001 Jul; 100(1):4-14. PubMed ID: 11414740
    [No Abstract]   [Full Text] [Related]  

  • 12. [Characteristics of the functional state of the lymphocytes in berylliosis studied by the blast transformation method].
    Shpakova AP; Ermakova NG
    Sov Med; 1979 Apr; (4):20-4. PubMed ID: 312533
    [No Abstract]   [Full Text] [Related]  

  • 13. Immune mechanisms in beryllium lung disease.
    Deodhar SD; Barna BP
    Cleve Clin J Med; 1991; 58(2):157-60. PubMed ID: 2025920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunology of sarcoidosis.
    Gerke AK; Hunninghake G
    Clin Chest Med; 2008 Sep; 29(3):379-90, vii. PubMed ID: 18539233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic beryllium disease in a precious metal refinery. Clinical epidemiologic and immunologic evidence for continuing risk from exposure to low level beryllium fume.
    Cullen MR; Kominsky JR; Rossman MD; Cherniack MG; Rankin JA; Balmes JR; Kern JA; Daniele RP; Palmer L; Naegel GP
    Am Rev Respir Dis; 1987 Jan; 135(1):201-8. PubMed ID: 3492158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular activation in the immune response of sarcoidosis.
    Zissel G
    Semin Respir Crit Care Med; 2014 Jun; 35(3):307-15. PubMed ID: 25007083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of differentially regulated mRNAs in monocytic cells induced by in vitro stimulation with Kveim-Siltzbach test reagent.
    Gaede KI; Kataria YP; Mamat U; Müller-Quernheim J
    Exp Lung Res; 2004; 30(3):181-92. PubMed ID: 15195552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunopathology of intestinal granulomatus disease.
    Thayer WR
    Front Gastrointest Res; 1975; 1():74-124. PubMed ID: 169196
    [No Abstract]   [Full Text] [Related]  

  • 19. Gamma/delta T-lymphocytes are not increased in number in granulomatous lesions of patients with tuberculosis or sarcoidosis.
    Tazi A; Fajac I; Soler P; Valeyre D; Battesti JP; Hance AJ
    Am Rev Respir Dis; 1991 Dec; 144(6):1373-5. PubMed ID: 1835826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon and growth factor activity for human lung fibroblasts. Release from bronchoalveolar cells from patients with active sarcoidosis.
    Moseley PL; Hemken C; Monick M; Nugent K; Hunninghake GW
    Chest; 1986 May; 89(5):657-62. PubMed ID: 3084179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.